cancer-screening

This test screens for 50 cancers — but whether Medicare and other health insurers will cover it hinges on FDA approval

Grail's Galleri blood test screens for 50 types of cancer from a single blood draw, but its path to wider insurance coverage depends on regulatory approval. A major study did not demonstrate that the test can reliably detect later-stage cancers, raising questions for Medicare and other payers about whether they will reimburse it.